Evidence map›Paper›PMID 30803995›Full record

ArticleCancer research2019

Targeted Metabolomics Identifies the Cytochrome P450 Monooxygenase Eicosanoid Pathway as a Novel Therapeutic Target of Colon Tumorigenesis.

Weicang Wang, Jun Yang, Matthew L Edin, Yuxin Wang, Ying Luo, Debin Wan, Haixia Yang, Chun-Qing Song, Wen Xue, Katherine Z Sanidad and 14 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Anti-Inflammatory Effects of Lipoxin A4 inAnimals : an open access journal from MDPI · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Metabolomics reveals soluble epoxide hydrolase as a therapeutic target for high-sucrose diet-mediated gut barrier dysfunction.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Plant Metabolomics: The Future of Anticancer Drug Discovery.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  17. Article
  18. Article
  19. Antioxidant Role of Probiotics in Inflammation-Induced Colorectal Cancer.International journal of molecular sciences · 2024
    Review
  20. SELENOI Functions as a Key Modulator of Ferroptosis Pathway in Colitis and Colorectal Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 8 institutions in 2 countries.

Weicang Wang *Department of Food Science, University of Massachusetts, Amherst, Massachusetts.
Jun Yang *Department of Entomology and Comprehensive Cancer Center, University of California, Davis, California.
Matthew L Edin *Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina.
Yuxin Wang *Department of Food Science, University of Massachusetts, Amherst, Massachusetts.
Ying LuoCenter for Nephrology and Metabolomics and Division of Nephrology and Rheumatology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Debin WanDepartment of Entomology and Comprehensive Cancer Center, University of California, Davis, California.
Haixia YangDepartment of Food Science, University of Massachusetts, Amherst, Massachusetts.
Chun-Qing SongRNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, Massachusetts.
Wen XueRNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, Massachusetts.
Katherine Z SanidadDepartment of Food Science, University of Massachusetts, Amherst, Massachusetts.ORCID 0000-0002-2689-3826
Mingyue SongDepartment of Food Science, University of Massachusetts, Amherst, Massachusetts.
Heather A BisbeeMolecular and Cellular Biology Graduate Program, University of Massachusetts, Amherst, Massachusetts.ORCID 0000-0003-0224-9128
Jennifer A BradburyDivision of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina.
Guanjun NanDepartment of Food Science, University of Massachusetts, Amherst, Massachusetts.
Jianan ZhangDepartment of Food Science, University of Massachusetts, Amherst, Massachusetts.
Pei-An Betty ShihDepartment of Psychiatry, University of California, San Diego, La Jolla, California.
Kin Sing Stephen LeeDepartment of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan.ORCID 0000-0003-4541-3063
Lisa M MinterMolecular and Cellular Biology Graduate Program, University of Massachusetts, Amherst, Massachusetts.
Daeyoung KimDepartment of Mathematics & Statistics, University of Massachusetts, Amherst, Massachusetts.ORCID 0000-0002-2223-2166
Hang XiaoDepartment of Food Science, University of Massachusetts, Amherst, Massachusetts.
Jun-Yan LiuCenter for Nephrology and Metabolomics and Division of Nephrology and Rheumatology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.ORCID 0000-0002-3018-0335
Bruce D HammockDepartment of Entomology and Comprehensive Cancer Center, University of California, Davis, California. guodongzhang@umass.edu zeldin@niehs.nih.gov bdhammock@ucdavis.edu.
Darryl C ZeldinDivision of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina. guodongzhang@umass.edu zeldin@niehs.nih.gov bdhammock@ucdavis.edu.
Guodong ZhangDepartment of Food Science, University of Massachusetts, Amherst, Massachusetts. guodongzhang@umass.edu zeldin@niehs.nih.gov bdhammock@ucdavis.edu.
University of Massachusetts Amherst · USNational Institute of Environmental Health Sciences · USUniversity of California, Davis · USShanghai Tenth People's Hospital · CNUniversity of Massachusetts Chan Medical School · USMichigan State University · USSouth China Agricultural University · CNUniversity of California San Diego · US

Funding

Workshop on Environmental Technology Transfer and EntrepreneurshipP42ES004699 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1987 to 2021
$50.1M
Viral Vector CoreP01HL131471 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FLOTTE, TERENCE R. · 2016 to 2020
$11.3M
HYDROLYTIC ENZYMES IN THE METABOLISM OF TOXINSR01ES002710 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1985 to 2018
$4.0M
P450 Arachidonate EpoxygenasesZ01ES025034 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI ZELDIN, DARRYL C · 1995 to 2008
$2.2M
Solving EPHX2 and PUFA Interactions in Anorexia NervosaR01MH106781 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SHIH, PEI-AN (BETTY) · 2016 to 2020
$2.0M
Identifying the receptors of environmentally sensitive epoxy-eicosanoids with AMSR00ES024806 · NIEHS · MICHIGAN STATE UNIVERSITY · PI LEE, KIN SING STEPHEN · 2017 to 2019
$727k
Prevention of colorectal cancer via targeting CYP epoxygenasesR03CA218520 · NCI · UNIVERSITY OF MASSACHUSETTS AMHERST · PI ZHANG, GUODONG · 2018 to 2019
$147k
Intramural NIH HHS Z01 ES025034NCI NIH HHS R03 CA218520NHLBI NIH HHS P01 HL131471NIEHS NIH HHS P42 ES004699NIEHS NIH HHS R00 ES024806NIEHS NIH HHS R01 ES002710NIMH NIH HHS R01 MH106781
6 · The paper itself

Abstract

Colon cancer is the third most common cancer and the second leading cause of cancer-related death in the United States, emphasizing the need for the discovery of new cellular targets. Using a metabolomics approach, we report here that epoxygenated fatty acids (EpFA), which are eicosanoid metabolites produced by cytochrome P450 (CYP) monooxygenases, were increased in both the plasma and colon of azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced colon cancer mice. CYP monooxygenases were overexpressed in colon tumor tissues and colon cancer cells. Pharmacologic inhibition or genetic ablation of CYP monooxygenases suppressed AOM/DSS-induced colon tumorigenesis

Indexed as

MetabolomicsAnimalsAntifungal AgentsApoptosisAzoxymethaneCarcinogenesisCell ProliferationClotrimazoleColonic NeoplasmsCytochrome P-450 Enzyme SystemDextran SulfateEicosanoidsEnzyme InhibitorsHumansMaleMiceAntifungal AgentsAzoxymethaneClotrimazolecytochrome P-450 CYP2C subfamilyCytochrome P-450 Enzyme SystemDextran SulfateEicosanoidsEnzyme InhibitorsProadifenRNA, Small Interfering

Identifiers

PMID30803995
PMCPMC6467714
OpenAlexW2917266179

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.